S100A8 is identified as a biomarker of HPV18 infected oral squamous cell carcinomas by suppression subtraction hybridization, clinical proteomics analysis and immunohistochemistry staining

中國醫藥大學機構典藏 China Medical University Repository, Taiwan > 中醫學院 > 中西醫結合研究所 > 期刊論文 > Item 310903500/2704

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.cmu.edu.tw/ir/handle/310903500/2704

题名:	S100A8 is identified as a biomarker of HPV18 infected oral squamous cell carcinomas by suppression subtraction hybridization, clinical proteomics analysis and immunohistochemistry staining
作者:	羅婉瑜(Lo, Wan-Yu);賴建成;花俊宏(Chun-Hung Hua);蔡銘修(Tsai,Ming-Hsui);黃宣(Shiuan-Yi Huang);蔡長海;蔡輔仁(Tsai,Fuu-Jen)*
贡献者:	中醫學院中西醫結合研究所;中國附醫醫學研究部
日期:	2007-06
上传时间:	2009-08-20 17:46:04 (UTC+8)
摘要:	The purpose of this work is to differentiate between the Human papillomaviruses 18 positive (HPV18+) and negative (HPV18−) oral squamous cell carcinomas (OSCC) in oral cancer patients with cancer-associated oral habits (betel quid chewing, cigarette smoking, and alcohol drinking). Both gene and protein expression profiles of HPV18+ and HPV18− OSCC were compared: we then further explored the biological effect of HPV in oral cancer. Suppression subtraction hybridization (SSH), clinical proteomics analysis, and immunohistochemistry (IHC) staining were carried out in the HPV18+ and HPV18− OSCC groups. HPV typing detection revealed that 11 OSCC tissues from 82 patients were positive for HPV18. The SSH experiment showed that 4 cancer-associated genes were highly transcribed within 11 cDNA libraries of HPV18+ OSCC, including poly(ADP-ribose)polymerase I (PARP1), replication protein A2 (RPA2), S100A8, and S100A2. Clinical proteomics analysis indicated that there was over 10-fold overexpression of Stratifin, F-actin capping protein alpha-1 subunit (CapZ alpha-1), Apolipoprotein A-1 (ApoA-1), Heat-shock protein 27 (HSP27), Arginase-1, p16INK4A, and S100 calcium-binding protein A8 (S100A8) in HPV18+ OSCC. Interestingly, the results from SSH and protemics analysis showed that S100A8 was overexpressed in HPV18+ OSCC. Moreover, IHC staining demonstrated that S100A8 was up-regulated in HPV18+ OSCC tissues. Our results suggest that S100A8 plays an important role in oral carcinogenesis following HPV18 infection; therefore, S100A8 may be a powerful biomarker of HPV18 as well as a potential therapeutic target for HPV18+ OSCC patients. The study is the first to identify S100A8 as a biomarker in HPV-associated cancer. Furthermore, this is also the first study to discover a biomarker by combining SSH, clinical proteomics, and IHC stain analysis in oral cancer-associated research.
關聯:	JOURNAL OF PROTEOME RESEARCH(6):2143~2151
显示于类别:	[中西醫結合研究所] 期刊論文

文件中的档案:

档案	大小	格式	浏览次数
	0Kb	Unknown	391	检视/开启

在CMUR中所有的数据项都受到原著作权保护.

TAIR相关文章

数据加载中.....